V8 Peptides — Engineered Performance
Research Library
Reconstituted Melanotan II Stability: Study Design
Melanotan IIReconstitution & Handling

Reconstituted Melanotan II Stability: Study Design

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

How long is reconstituted melanotan II stable? No source cited here establishes a shelf life for it, and this page does not invent one. What it offers is a way for a laboratory to measure stability in its own solvent, container and temperature: prepare a stock, hold aliquots under defined conditions, and compare each time point with a freshly prepared reference by HPLC, using first-order decay arithmetic and a pre-set acceptance limit. The sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 contains a tryptophan and a histidine, residues that general reviews list among oxidation-prone ones (Li et al., 1995). For laboratory research use only; see the MT-2 product page and melanotan II research overview.

Everyone who works with a reconstituted peptide eventually asks how long the solution stays good. The honest answer is that it depends on the solvent, pH, container, temperature, light and what the assay can tolerate, and the only reliable number is one you measure. This article lays out a small, practical stability study that a lab can run with an HPLC and a freezer, and explains how to read the result. It deliberately does not state a duration; for general background on solution storage see how long reconstituted peptides last, and for the dry vial see our guide to storage of the lyophilized material. The material is supplied for laboratory research use only; not for human consumption.

What changes when a peptide goes into solution

A lyophilized solid has very little water, which limits the mobility and reactivity of the molecule; a review of solid protein pharmaceuticals notes that proteins are often lyophilized to achieve an acceptable shelf life, while cautioning that solid-state proteins may still have limited long-term storage stability (Wang, 2000). Once the powder is dissolved, the molecule is free in water and the full set of solution degradation routes becomes available. A broad review of protein stability covers chemical and physical instability and stabilization in aqueous solution and in the dried state (Manning et al., 2010). Chemical routes include oxidation and hydrolysis; physical routes include adsorption, aggregation and precipitation.

For MT-2 specifically, the ring and the D-residue are designed against enzymatic breakdown, as the 1980 analog work showed for the linear parent, which resisted degradation by serum enzymes (Sawyer et al., 1980). Enzymes are therefore not the main worry in a sterile buffer. What remains are chemical routes. Oxidation of tryptophan is one: Li and colleagues' review of chemical instability lists methionine, cysteine, histidine, tryptophan and tyrosine as the most oxidation-prone residues and notes that oxidants, metal ions and light can all drive it (Li et al., 1995). Norleucine, by design, replaces methionine, so the sulfur-based route is absent. Physical loss by adsorption to tubes is a further, often underestimated, source of apparent instability (Goebel-Stengel et al., 2011).

Designing the study

A stability study answers one question: under condition X, how much intact peptide remains at time t relative to time zero? The design needs five decisions made before any vial is opened.

  1. Define the conditions. Typically the solvent used in the real assay, the container used in the real assay, and two or three temperatures (for example refrigerated, room temperature, and frozen aliquots thawed once).
  2. Define the time points. A schedule that is dense early and sparse later (for example time zero, then increasing intervals) catches both fast and slow processes.
  3. Define the reference. A fresh solution prepared on the day of analysis from the same lyophilized lot, so the analytical run itself is controlled.
  4. Define the readout. Peak area of the main peak on a stability-indicating HPLC method, plus appearance of new peaks, plus (if the lab has it) a mass check on any new species.
  5. Define the acceptance limit in advance. For example, that the main peak must remain within a stated percentage of the reference. The number is the lab's decision and depends on assay tolerance; it should be written down before the data arrive.

The table shows a layout that works for small labs.

ArmConditionPurposeReadout
AWorking solution at assay temperature in assay bufferIs the peptide intact for the length of one experiment?Main-peak area vs fresh reference
BRefrigerated stock in its containerHow long can a stock be kept between experiments?Main-peak area; new peaks
CFrozen single-use aliquots, thawed onceDoes freezing preserve the stock?Recovery after thaw
DSame stock in a second container typeDoes the tube material matter?Measured concentration vs nominal
EDeliberately stressed aliquot (warm, light)Can the method see degradation products?New peaks; peak purity

The arithmetic of decay and acceptance

Many peptide degradation processes in dilute solution are approximated as first order, in which the rate of loss is proportional to the amount remaining: C(t) = C0 × e−kt, equivalently ln(C/C0) = −kt. Plotting the natural log of the fraction remaining against time should give a straight line of slope −k if the model fits. The time at which 10% is lost follows from the same relation: t90 = ln(1/0.9) / k ≈ 0.105 / k, and the half-life is t1/2 = ln 2 / k ≈ 0.693 / k. These are formulas, not claims about MT-2: the value of k has to come from your data, and a non-linear plot signals that more than one process is operating (for instance, fast adsorption followed by slow chemical loss).

Two corrections prevent misreading. First, express every time point as a percentage of the same-day fresh reference, not of the time-zero run of an earlier day, because instrument response drifts. Second, distinguish loss of peak area from appearance of new peaks: a result that loses area without new peaks suggests adsorption or precipitation, whereas new peaks suggest chemical change. Recovery is calculated as % recovery = (area at t / area of fresh reference) × 100, and each time point should be run in at least duplicate.

Sources of loss that are not degradation

Concentrations of working solutions are often low, and adsorption to container walls is proportionally larger as concentration falls. The study of plasticware and glassware for peptides found that the choice of container material affects recovery of peptides, and recommends selecting the optimal material and checking recovery rather than assuming it (Goebel-Stengel et al., 2011). In a stability experiment this appears as a drop in the first hours that then flattens, which looks like fast degradation but is a surface equilibrium.

Other non-chemical effects include evaporation from loosely capped tubes, concentration changes from freeze-thaw ice-front effects, and cloudiness from solubility limits. Forced-degradation practice from the formulation field is a useful template here: stress the sample deliberately to learn what the degradation products look like and to confirm that the analytical method can detect them (Hawe et al., 2012). If a warmed and light-exposed aliquot gives new peaks that resolve from the main peak, the method is stability-indicating; if it shows nothing, the method may be blind to the changes of interest. Note that cloudiness after reconstitution is its own topic, covered in cloudy peptide vial after reconstitution.

SymptomPossible causeCheck
Rapid early drop that plateausAdsorption to tubeRepeat in a different container; measure concentration
Steady decline, no new peaksSlow loss to surface or precipitationCentrifuge and re-run the supernatant; inspect
Steady decline with new peaksChemical degradationMass check of new peaks; compare to stressed sample
Variable results between replicatesPipetting or evaporationReplicate preparation; cap tubes tightly
Cloudy solutionSolubility limit or aggregationDilute; check pH and solvent

Turning results into a rule for your lab

The output should be a one-line, lab-specific rule: for example, that a stock held under condition B is used within a stated number of days and a working dilution within a stated number of hours, backed by the time course. Record the rule with the lot number and date, and revisit it when the solvent, container, assay or lot changes. A result for one lot does not automatically carry to the next, so keep the COA where one is published alongside the study record; the MT-2 product page lists a COA as coming soon at the time of writing, so confirm before relying on it.

The practical habits that support any rule are: prepare stock from a vial equilibrated to room temperature before opening; keep stock volumes small so they are used before the rule's limit; avoid repeated freeze-thaw by dividing into single-use aliquots; protect from light; and log every handling step. The arithmetic for the stock is on peptide reconstitution volume calculations and the calculator, and a stepwise handling explanation is at how to reconstitute a lyophilized peptide. For the broader catalog see the shop.

What this page does not claim

It does not claim a shelf life for reconstituted MT-2, does not claim that any given solvent preserves it, and does not report data from V8 on solution stability. The product page states storage for the lyophilized material only: refrigerate at 2–8 °C, or −20 °C for long term, protected from heat, moisture and light, in a 10 mg lyophilized powder of at least 98% HPLC purity. Everything else here is method.

Frequently asked questions

How long does reconstituted MT-2 last?

No source cited on this page gives a number. Stability depends on solvent, pH, container, temperature and light, and should be measured by the lab with HPLC against a fresh reference.

What residues are at risk in solution?

Tryptophan and histidine are on the list of oxidation-prone residues in the chemical-instability literature (Li et al., 1995). Norleucine replaces methionine in this sequence.

Why do enzymes matter less here?

The 1980 analog with the same D-phenylalanine and norleucine changes resisted degradation by serum enzymes (Sawyer et al., 1980); sterile buffers contain no such enzymes anyway.

What does t90 mean?

The time to 10% loss, t90 ≈ 0.105/k for first-order decay, where k is the fitted rate constant.

How do I tell adsorption from degradation?

Adsorption causes area loss without new peaks and often flattens early; degradation usually creates new peaks. Testing a different container helps.

Do container materials matter?

Yes. Peptide recovery differs between plastics and glass (Goebel-Stengel et al., 2011).

Why include a stressed sample?

To confirm the HPLC method can see degradation products, the logic of forced degradation (Hawe et al., 2012).

What should be compared against what?

Each time point against a freshly prepared reference run the same day, not against an earlier day's run.

Does freezing solve the problem?

Not automatically; freeze-thaw can itself cause loss, so single-use aliquots thawed once are tested as a separate arm.

Where does the dry vial's storage guidance come from?

The product page: 2–8 °C, or −20 °C long term, protected from heat, moisture and light.

Responsible research use

Everything on this page is offered for laboratory research use only; it is background reading for qualified researchers, not guidance for any use outside a research setting, and nothing here is a claim about benefit in people or animals. Products from V8 Peptides are sold strictly as research materials: not a drug, food or cosmetic, and not for human or animal consumption. Published studies described here were run by their authors under their own approvals and protocols, and this page does not recommend repeating them.

Related reading: Melanotan II Reconstitution Math and Study Reporting, Melanotan II Research Models: Cell Lines and Bioassays, Melanotan II Storage: Temperature, Moisture and Light.

References

  1. Sawyer TK, Sanfilippo PJ, Hruby VJ, Engel MH, Heward CB, Burnett JB, Hadley ME. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci U S A. 1980;77(10):5754-5758. doi:10.1073/pnas.77.10.5754
  2. Li S, Schöneich C, Borchardt RT. Chemical instability of protein pharmaceuticals: mechanisms of oxidation and strategies for stabilization. Biotechnol Bioeng. 1995;48(5):490-500. doi:10.1002/bit.260480511
  3. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
  4. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. doi:10.1016/S0378-5173(00)00423-3
  5. Hawe A, Wiggenhorn M, van de Weert M, Garbe JHO, Mahler HC, Jiskoot W. Forced degradation of therapeutic proteins. J Pharm Sci. 2012;101(3):895-913. doi:10.1002/jps.22812
  6. Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.